Nikolay Savchuk insider trades
Open-market stock purchases and sales by Nikolay Savchuk, Chief Operating Officer at Traws Pharma, Inc, from SEC Form 4 filings since Apr 1, 2024.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -97%.